Overexpression of CDK20 was found in glioblastoma tumor tissue and glioma cell lines compared to the normal tissue, while siRNA silencing of CDK20 inhibited growth and reduced CDK2 phosphorylation in U-373 MG and U-87 MG glioblastoma cells [141]. This evidence concerns the gene CDK20 and central nervous system cancer.